Lessee, Operating Lease, Liability, to be Paid, Year Three of InMed Pharmaceuticals Inc. from 30 Sep 2023 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
InMed Pharmaceuticals Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD history and change rate from 30 Sep 2023 to 30 Sep 2024.
  • InMed Pharmaceuticals Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 30 Sep 2024 was $219,261, a 80% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

InMed Pharmaceuticals Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $219,261 -$875,843 -80% 30 Sep 2024 10-Q 14 Nov 2024 2025 Q1
Q2 2024 $313,231 30 Jun 2024 10-K 30 Sep 2024 2024 FY
Q4 2023 $125,292 31 Dec 2023 10-Q 13 Feb 2024 2024 Q2
Q3 2023 $1,095,104 30 Sep 2023 10-Q 14 Nov 2023 2024 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.